u/ffmi_watcher

Agreed that the published criteria are the authority. They are searchable and most people never look.

Kept the script and the receipt for a private health claim and both were requested.

STEP-1 ran 68 weeks and landed just under 15% mean body weight change on 2.4mg. It is an average of a wide distribution, not a target you have missed.

Paid noticeably more at one clinic than another for what turned out to be the same facility behind both.

Disagree that this is a discrepancy. 99.0% against a claimed 98.5% is inside ordinary inter-lab variance in either direction.

If the report gives a mass spectrum as well as UV purity, say so. Identity and relative quantity are separate claims and the log tracks both.

do not chase somebody else’s titration schedule, they are not you

Sceptical of the mechanism you are proposing. Gastric emptying slows, it does not stop, and the timings you describe do not follow from it.

Yes. Week 29 is when almost everybody writes the "is it still working" post, and almost everybody is fine.

say the province or the answers will be wrong

Small fix — same supplier, different lot. The two rows in the log are not the same batch.

Registration by the therapeutic goods regulator establishes that a product may be supplied.

lipid_panel_larry is right that the two countries are separate systems and the answers diverge.

the injection is easier than you are imagining

the ladder exists because the gut needs the time, not because the pharmacy likes paperwork

Inter-lab variance on this assay runs roughly a point either way, driven mostly by gradient and integration. Two results inside that band agree; they do not disagree quietly.

Is this about registration or about subsidy?

say which state only if it matters, but always say which country

Agreed — week two with nothing on the scale is so common it should be in the sidebar. It probably is.

The template is vendor, compound, batch, service, claim, result, and who paid. Every one of those fields exists because a result missing it has been argued about here before.

How to ask a question here so that you get a useful answer.

Say what week you are in, whether you are using a pen or a vial, what country you are in, and what you have already read. Those four facts turn a question that gets three contradictory answers into one that gets a specific one.

And do ask. The basic questions get searched for constantly, so a clear answer here helps a stream of people who will never post. The only genuinely unwelcome thing on this board is being unpleasant to somebody for not knowing something yet.

the label on a compounded vial is a legal document, read it

This. Compounded preparations carry no equivalence claim, and treating them as generics is a category error people make constantly.

Small fix — same supplier, different lot. The two rows in the log are not the same batch.

Read the published criteria for my indication rather than asking. Twenty minutes, and it answered everything I had been guessing at.

What is the beyond-use date and what is it based on?

the scale is the least sensitive instrument you own

That figure is the 68-week trial mean, not a weekly rate. Dividing it by the weeks gives you a number that does not mean anything.

Small correction: 2.4mg is the maintenance ceiling on the label, not the starting maintenance dose.

Disagree with this specific line. A pause at 0.5mg is not evidence that 0.5mg has stopped working.

STEP-1 ran 68 weeks and landed just under 15% mean body weight change on 2.4mg. It is an average of a wide distribution, not a target you have missed.

Careful, that criterion was updated at renewal and the version you are quoting is superseded.

Correction: that is regulatory approval, not coverage. They are separate decisions by separate bodies.

Compared cash prices across four pharmacies before pursuing coverage and the spread was larger than I expected.

Have you asked the pharmacist to check?

The mental model that finally made this click for me: there are two curves, and people watch the wrong one.

The first is exposure, which is set by the dose and smoothed by a week-long half-life. It changes when you change the dose and then settles over about a month. The second is body weight, which is exposure filtered through appetite, food, water, sleep, training and the scale itself, and which moves in steps rather than a line.

Almost every "it stopped working" post is somebody watching curve two over a fortnight and drawing conclusions about curve one. If the appetite effect is still there, exposure is fine. Wait the month.

Week 60: 29kg down, injection-site soreness basically gone since about week 10, and the honest headline is that nothing dramatic happened. It was boring and it worked.

I confused two very similar words on my first order and asked here, expecting to be mocked. Three people explained it properly instead.

That is area percent from a certificate, not the amount of peptide in the vial. Two different numbers and a very common mix-up.

PBS listing and TGA registration are two different questions

do not assume the concentration matches the branded product

Disagreeing with this bit: registration is not equivalence, and the two get run together constantly.

Minor fix — the half-life is about a week, not about a day. The rest of your point stands.